Silver Spur TX
Techstars '25Palos Verdes Peninsula, US · 1 known investors
Silverspurt develops a peptide amphiphile micelle platform for precise, tissue-targeted delivery of small-molecule drugs and genetic therapeutics, reducing systemic toxicity and off-target effects. The platform is designed to improve therapeutic efficacy and patient compliance across multiple therapeutic modalities.